IgA肾病国际风险预测模型在亚裔-高加索人群中的外部验证
本研究在1275例中国和阿根廷IgA肾病患者中外部验证了两个基于临床变量和牛津MEST评分的预测模型,主要结局为eGFR下降50%或终末期肾病。模型C统计量为0.81,校准可接受(不含种族的全模型),但含种族的全模型高估了3年以上风险概率。
要点
- 两个IgA肾病预测模型在亚裔-高加索队列中区分度良好,C统计量为0.81。
- 不含种族的全模型校准可接受,含种族的全模型高估3年以上风险概率。
- 模型可用于个体化风险分层,辅助精准治疗决策。
核心结论
- 预测模型在个体化风险评估中表现良好,可能用于药物特异性精准医学治疗决策。
研究设计与样本
- 多中心外部验证研究,纳入活检证实的中国和阿根廷IgA肾病患者共1275例,平均年龄34岁(IQR 27-42),男性638例(50%)。
主要发现
- 模型C统计量为0.81,决定系数(R2 D)高于既往报道。
- 按线性预测值百分位分组的生存曲线分离良好。
- 大多数预测变量(包括风险比、预测5年风险和eGFR下降斜率)随风险增加而变差。
- 基线生存函数与本队列和已报道队列相当。
- 不含种族的全模型校准可接受,但含种族的全模型高估3年以上风险概率。
关键数值与推荐
- 主要结局定义为eGFR下降50%或终末期肾病。
- 使用C统计量评估区分度,R2 D评估模型拟合,校准图评估校准。
临床怎么用
- 可将模型用于IgA肾病患者个体化风险分层,辅助治疗决策。
- 使用含种族的全模型时需注意3年以上风险概率可能被高估。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Two prediction models for IgA nephropathy (IgAN) using clinical variables and the Oxford MEST scores were developed and validated in 2 multiethnic cohorts. Additional external validation is required. METHODS: Biopsy-proven Chinese and Argentinian patients with IgAN were included. The primary outcome was defined as a 50% decline in estimated glomerular filtration rate (eGFR) or end-stage renal disease. C-statistics and stratified analyses were used for model discrimination, coefficient of determination (R2 D) for model fit, and calibration plots for model calibration. Baseline survival function was also evaluated. RESULTS: A total of 1275 patients were enrolled, with a mean age of 34 (interquartile range: 27-42) years, 50% of whom (638 of 1275) were men. Use of renin-angiotensin system blockers was higher than in previously reported cohorts, whereas other variables were comparable. The C-statistic of the models was 0.81, and R2 D was higher than reported. Survival curves in the subgroups (<16th, ∼16th to <50th, ∼50th to <84th, and ≥84th percentiles of linear predictor) were well separated. Most of the predictor variables, including hazard ratio, predicted 5-year risk, and eGFR decline slope, were worse with risk increasing. The baseline survival function was comparable in our cohort and the reported cohorts. The calibration was acceptable for the full model without race. However, the risk probability over 3 years was overestimated in the full model with race included. CONCLUSION: The prediction models showed good performance on personalized risk assessment, which may be used as drug-specific, precision-medicine approaches to treatment decisionmaking.
引用
- Zhang Y, Guo L, Wang Z, et al. External Validation of International Risk-Prediction Models of IgA Nephropathy in an Asian-Caucasian Cohort. Kidney Int Rep. 2020. PMID: 33102968. doi:10.1016/j.ekir.2020.07.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。